Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Case Report



An Unprecedented Behaviour Of Placental Site Trophoblastic Tumor: a case report

Jasmina Begum,Priyadarshini Nayak,Susama Patra,Swagatika Samal.

Abstract
Placental site trophoblastic tumor (PSTT) is a rare form of gestational trophoblastic neoplasia with unclear risk factors. The nonspecific and uncharacteristic clinical and biochemical presentation and the rarity of these malignancies makes the diagnosis of PSTT often difficult thereby leading to a low preoperative diagnosis. Here, we report a case of PSTT with nonspecific and uncharacteristic behavior leading to dilemma in diagnosis and who also had vascular tumor emboli on histopathological examination. She was treated with hysterectomy for PSTT, and subsequently developed an occult isolated CNS metastasis for which she received 6 cycles of EMA/EP chemotherapy. At the latest follow-up, the patient's course was satisfactory, and she exhibited no signs of tumor recurrence. The rarity, uncharacteristic behavior and its successful outcome in management mandates this case to be reported.

Key words: Placental site trophoblastic tumor (PSTT), Gestational trophoblastic disease (GTD), chemotherapy, Immunochemistry



Similar Articles

Disparities in Genetic Testing for Heritable Solid-Tumor Malignancies.
Dillon J, Ademuyiwa FO, Barrett M, Moss HA, Wignall E, Menendez C, Hughes KS, Plichta JK
Surgical oncology clinics of North America. 2022; 31(1): 109-126

Exploring the Alzheimer's disease neuroepigenome: recent advances and future trends.
Zhang H, Elefant F
Neural regeneration research. 2022; 17(2): 325-327

MTA1, a metastasis‑associated protein, in endothelial cells is an essential molecule for angiogenesis.
Ishikawa M, Osaki M, Uno N, Ohira T, Kugoh H, Okada F
Molecular medicine reports. 2022; 25(1):

Editorial: Novel therapeutic approaches in chronic kidney disease and kidney transplantation: the draw of evolving integrated multimodal approaches in the targeted therapy era.
Tantisattamo E, Hanna RM, Kalantar-Zadeh K
Current opinion in nephrology and hypertension. 2022; 31(1): 1-5

Growth differentiation factor 5: a neurotrophic factor with neuroprotective potential in Parkinson's disease.
Goulding SR, Anantha J, Collins LM, Sullivan AM, O'Keeffe GW
Neural regeneration research. 2022; 17(1): 38-44


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites